Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030

Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Dec. 19, 2025 /PRNewswire/ —USA News Group…

BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook

BioMarin to Gain Galafold® (migalastat) for Fabry Disease and Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) for…

Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines

Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Dec. 19, 2025 /PRNewswire/ — Equity Insider…

Peer-Reviewed Studies Validate Linus Health AI as an Early Digital Biomarker for Alzheimer’s Pathology, Helping People Take Action Earlier to Slow Disease Impact

Findings show Linus Health’s AI can indicate Alzheimer’s pathology before noticeable symptoms—enabling earlier action to help…

The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute

IRVING, Texas, Dec. 19, 2025 /PRNewswire/ –Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI…

Xtalks Life Science Podcast Wraps Up 2025 with Deep Dives into Drug Development, Regulation, Clinical Trials and Innovation, Sets Sights on a Transformative 2026 by Xtalks

In 2025, the Xtalks Life Science Podcast featured conversations with industry leaders across pharma, biotech, medtech…

Oak Harvest Financial Group Announces Title Sponsorship of 12th Annual St. Jude Houston Golf Classic

HOUSTON, Dec. 19, 2025 /PRNewswire/ — Oak Harvest Financial Group is proud to announce its role…

Parent Talk with Dr. Ambroes Premieres December 19, 2025

A Powerful New Podcast Giving Voice, Hope, and Practical Guidance to Parents MIDLAND, Ga., Dec. 19,…

HCAP Partners Announces Investment in Puzzle Healthcare

Investment to accelerate the growth of a post-acute care platform focused on reducing hospital readmissions and…

Mercury Bio and Meta-Flux Announce Strategic Collaboration to Advance Large-Molecule Therapeutics for Parkinson’s and Alzheimer’s Diseases

SANTA FE, N.M. and CAMBRIDGE, Mass., Dec. 19, 2025 /PRNewswire/ — Mercury Bio, a biotechnology company…